Compare 10X Genomics Inc (TXG) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs US Bancorp — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 17.9× 10X Genomics Inc's market cap, and US Bancorp pays a 3.29% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | USB | |
|---|---|---|
Market Cap | $5.48B | $98.36B |
Sector | Health | Financials |
52-Week High | $45.80 | $64.01 |
52-Week Low | $11.34 | $43.94 |
Enterprise Value | $5.02B | — |
Dividend Yield | — | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
